Tafamidis treatment for patients with transthyretin amyloid cardiomyopathy
Original Article from The New England Journal of Medicine — Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy
Gespeichert in:
| Hauptverfasser: | , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
September 13, 2018
|
| In: |
The New England journal of medicine
Year: 2018, Jahrgang: 379, Heft: 11, Pages: 1007-1016 |
| ISSN: | 1533-4406 |
| DOI: | 10.1056/NEJMoa1805689 |
| Online-Zugang: | Verlag, Volltext: https://doi.org/10.1056/NEJMoa1805689 Verlag, Volltext: https://www.nejm.org/doi/10.1056/NEJMoa1805689 
|
| Verfasserangaben: | Mathew S. Maurer, Jeffrey H. Schwartz, Balarama Gundapaneni, Perry M. Elliott, Giampaolo Merlini, Marcia Waddington-Cruz, Arnt V. Kristen, Martha Grogan, Ronald Witteles, Thibaud Damy, Brian M. Drachman, Sanjiv J. Shah, Mazen Hanna, Daniel P. Judge, Alexandra I. Barsdorf, Peter Huber, Terrell A. Patterson, Steven Riley, Jennifer Schumacher, Michelle Stewart, Marla B. Sultan, and Claudio Rapezzi for the ATTR-ACT study investigators |
| Zusammenfassung: | Original Article from The New England Journal of Medicine — Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy |
|---|---|
| Beschreibung: | Gesehen am 18.10.2019 |
| Beschreibung: | Online Resource |
| ISSN: | 1533-4406 |
| DOI: | 10.1056/NEJMoa1805689 |